Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/7591267

Int. J. Cancer 1995 Nov 15 63 4 560-7

Download in:

View as

General Info

PMID
7591267